Allelic expression of p73 in human ovarian cancers

被引:19
作者
Codegoni, AM
Bertoni, F
Patregnani, C
Marinetti, E
D'Incalci, M
Broggini, M
机构
[1] Ist Ric Farmacol Mario Negri, Mol Pharmacol Unit, Dept Oncol, I-20157 Milan, Italy
[2] Univ Milan, Osped S Gerardo, Monza, Italy
关键词
allelic expression; borderline tumors; ovarian cancer; p73; tumor suppressor gene;
D O I
10.1023/A:1008320609591
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The p73 gene is structurally related to the tumor suppressor gene p53. The role of p73 in tumor development is still unclear and no data on ovarian cancer are so far available. For this reason we have analyzed, in a panel of ovarian cancers, the allelic distribution and expression of p73. Patients and methods: Fifty-one samples from ovarian cancers and five human ovarian cancer cell lines growing in culture were analyzed. Allelic origin was analyzed by PCR after digestion with the restriction enzyme Sty I. Heterozygous, informative cases were selected for studies aimed at evaluating allelic expression of p73. Results: We found an allelic distribution similar to that previously reported. LOH was found in two patients with ovarian cancer. In one case in which normal ovarian tissue was available biallelic expression of p73 was found. Conclusion: In comparisons of ovarian cancers and borderline tumors, no differences in allelic distribution and/or expression were found, suggesting that p73 does not play an important role in the pathogenesis and development of ovarian cancer.
引用
收藏
页码:949 / 953
页数:5
相关论文
共 29 条
[1]   MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS [J].
DONEHOWER, LA ;
HARVEY, M ;
SLAGLE, BL ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A .
NATURE, 1992, 356 (6366) :215-221
[2]  
GALLION HH, 1995, CANCER, V76, P1992, DOI 10.1002/1097-0142(19951115)76:10+<1992::AID-CNCR2820761315>3.0.CO
[3]  
2-U
[4]   The 1995 Walter Hubert lecture - Molecular epidemiology of human cancer: Insights from the mutational analysis of the p53 tumour-suppressor gene [J].
Harris, CC .
BRITISH JOURNAL OF CANCER, 1996, 73 (03) :261-269
[5]   CLINICAL IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE [J].
HARRIS, CC ;
HOLLSTEIN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (18) :1318-1327
[6]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[7]  
Hollstein M, 1997, Recent Results Cancer Res, V143, P369
[8]   Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers [J].
Kaghad, M ;
Bonnet, H ;
Yang, A ;
Creancier, L ;
Biscan, JC ;
Valent, A ;
Minty, A ;
Chalon, P ;
Lelias, JM ;
Dumont, X ;
Ferrara, P ;
McKeon, F ;
Caput, D .
CELL, 1997, 90 (04) :809-819
[9]  
KAGHAD M, 1998, 9 P53 WORKSH, P65
[10]  
Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897